These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20360147)

  • 1. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
    Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
    Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
    Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
    Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
    Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
    Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
    Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
    J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
    Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
    Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
    Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D
    Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
    Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D
    Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients.
    Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
    Clin Chim Acta; 2012 Oct; 413(19-20):1668-74. PubMed ID: 22664146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
    Yang TF; Guo L; Wang Q
    Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk.
    Gremlich S; Nguyen D; Reymondin D; Hohlfeld P; Vial Y; Witkin SS; Gerber S
    J Reprod Immunol; 2007 Jun; 74(1-2):143-51. PubMed ID: 17367869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
    Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
    Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
    Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
    Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.